LN ROBOTICS
Advancing cardiovascular care through robotic precision
Seoul, South Korea · Founded 2019 · $14.5M raised
- Headquarters
- Seoul
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- lnrobo.com
- Total Funding
- $14.5M
- Last Round
- $14.5M Series BJul 2024
- Rounds
- 2
About
LN Robotics is a South Korean medical robotics company founded in 2019 that develops the AVIAR vascular robotic system for percutaneous coronary interventions (PCI). The system automates catheter manipulation to improve precision and reduce radiation exposure for both clinicians and patients during cardiovascular procedures. AVIAR received an Innovative Medical Technology designation in South Korea and entered full clinical use at Asan Medical Center in 2026. The company targets interventional cardiologists and cath lab operators seeking robotic-assisted tools for complex vascular procedures.
Summary
LN ROBOTICS is a Healthcare company based in Seoul, South Korea, founded in 2019. It has raised $14.5M in total across 2 rounds, most recently a $14.5M Series B round in Jul 2024. Investors include Industrial Bank of Korea, KB Investment and LB Investment.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

